The abcd1 mutant zebrafish model exhibits features of human ALD (e.g., elevated VLCFA levels, alterations in CNS and the interrenal organ) and has been successfully used for high-throughput drug screening to identify therapeutic compounds for ALD patients. Here, ABCD1 is linked to adrenoleukodystrophy.